On November 5, Team Gluten-Free runners unite to run the 2023 TCS NYC Marathon with the common goal of accelerating diagnosis, treatments, and a cure for the 3 million Americans affected by celiac disease. We are so grateful to these six runners for their inspiring efforts and invite you to learn more about what drives them to support our collective mission.
Continue ReadingThe Cribsiders Podcast on pediatric medicine recently released an episode with a special guest, Dr. Dale Lee from Seattle Children's Hospital, about the diagnosis and management of celiac disease.
Continue ReadingA recent study evaluated the prevalence of detectable gluten immunogenic peptides (GIPs), which are resistant to digestion and are excreted through the stool and urine, to gauge accidental gluten exposure and adherence to a gluten-free diet in children with celiac disease in the United States.
Continue ReadingCeliac disease world expert Alessio Fasano, MD, recently wrote a commentary on a study that set out to identify a link between inflammatory bowel disease and celiac disease/celiac autoimmunity in children and adults.
Continue ReadingAt CDF, we deeply value hearing stories from our patient community. Your stories are a pivotal part of our efforts to build awareness and fight for research funding.
Continue ReadingThe Celiac Disease Foundation is proud to continue our partnership with the Celiac Disease Center at Columbia University in presenting an annual free livestream international symposium, this year titled “Celiac Disease: On the Horizon”. Recording available now.
Continue ReadingThe Celiac Disease Foundation, is proud to announce a recent grant of $200,000 from the Foster Family Foundation, which CDF will use to further its mission.
Continue ReadingThe Celiac Disease Foundation today announces the departure of Chief Development Officer Deborah Ceizler, who has served in key roles for more than 18 years.
Continue ReadingResearch is pivotal to the mission of the Celiac Disease Foundation, and so I’m excited to provide you with an update on the groundbreaking findings of a recent study conducted for the European Union’s Joint Research Centre (JRC).
Continue ReadingWant to get involved in celiac disease research? It’s time to take action. The TEV-CeD Study is a phase 1b clinical trial testing the investigational medication TEV-53408 for the treatment of celiac disease.
Continue ReadingHere at the Celiac Disease Foundation, we deeply value hearing stories from our patient community. Elevating the lived experience of people navigating celiac disease and recognizing the good work of our patient advocates are important ways to build community among our patients, caregivers, and supporters worldwide. Your stories are also...